ITGA2B and COVID-19: We observed that platelet fibrinogen binding (detected with a fluorescently labeled polyclonal antibody) was decreased in COVID-19 patients compared to COVID-19 negative control patients, which suggested a decreased activation of GPIIb/IIIa (Supplementary Figure 3).